1. "2019"
Formats
  1. Journal Article (2144)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2450)
  2. Solid Tumor Oncology Division (1408)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (937)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5611)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TATTON expansion cohorts: A phase Ib study of osimertinib plus savolitinib in patients (pts) with EGFR-mutant, MET-positive NSCLC following disease progression on a prior EGFR-TKI
    Meeting Abstract

    Han, J. Y.; Sequist, L. V.; Ahn, M. J.; Cho, B. C.; Yu, H.; Kim, S. W.; Yang, J. C. H.; Lee, J. S.; Su, W. C.; Kowalski, D.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer
    Meeting Abstract

    Hyman, D.; Tan, D. S. W.; van Tilburg, C.; Albert, C.; Geoerger, B.; Farago, A.; Laetsch, T.; Kummar, S.; Doz, F.; Lassen, U.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant pembrolizumab (pembro) plus standard of care (SOC) in patients (pts) with resectable locally advanced (LA) head and neck squamous cell carcinoma (HNSCC): The phase III KEYNOTE-689 study
    Meeting Abstract

    Cohen, E.; Uppaluri, R.; Lee, N.; Westra, W.; Haddad, R.; Temam, S.; Le Tourneau, C.; Chernock, R.; Safina, S.; Tao, Y.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Patient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS)
    Meeting Abstract

    Friedlander, M. L.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Entrectinib in locally advanced/metastatic ROS1 and NTRK fusion-positive non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
    Meeting Abstract

    de Braud, F.; Siena, S.; Barlesi, F.; Drilon, A.; Simmons, B.; Huang, X.; Osborne, S.; Doebele, R. C.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients
    Meeting Abstract

    Galon, J.; Hermitte, F.; Mlecnik, B.; Marliot, F.; Bifulco, C.; Lugli, A.; Nagtegaal, I.; Hartmann, A.; van den Eynde, M.; Roehrl, M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Asparagine ethylenediamines as anti-malarial plasmodium-selective proteasome inhibitors
    Meeting Abstract

    Zhan, W.; Visone, J.; Harris, J.; Ouellette, T.; Wang, R.; Zang, H.; Singh, P.; Ginn, J.; Sukenick, G.; Wong, T. T.; more...
    American Journal of Tropical Medicine and Hygiene (2019)

    Fulltext@MSK | Save
  • Outcomes based on albumin-bilirubin (ALBI) grade in the phase III CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Chan, S. L.; Miksad, R.; Cicin, I.; Chen, Y.; Klumpen, H. J.; Kim, S.; Lin, Z. Z.; Youkstetter, J.; Sen, S.; Cheng, A. L.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Stem cell-driven lymphatic remodeling coordinates tissue regeneration
    Journal Article

    Gur-Cohen, S.; Yang, H.; Baksh, S. C.; Miao, Y.; Levorse, J.; Kataru, R. P.; Liu, X.; de la Cruz-Racelis, J.; Mehrara, B. J.; Fuchs, E.
    Science (2019)

    Fulltext@MSK | Save
  • Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer
    Journal Article

    Coleman, R. L.; Fleming, G. F.; Brady, M. F.; Swisher, E. M.; Steffensen, K. D.; Friedlander, M.; Okamoto, A.; Moore, K. N.; Ben-Baruch, N. E.; Werner, T. L.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save